The study reported reduced tumor growth with gemcitabine alone or in combination with a CXCR4 antagonist (AMD3100) or hedgehog inhibitor (GDC-0449) in orthotopic pancreatic tumor-bearing mice. The gene discussed is CXCR4; the disease is pancreatic neoplasm.